Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

13,034

rulemaking dockets

4,738

open for public comment

You can weigh in on these right now

Showing 30 of 13,034 dockets

Nonrulemaking

NRCS

NRCS-2025-0203

USDA Seeks Comment on Updated Reporting for Urban Agriculture Grants

1 doc5 comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-3104

Requests that the FDA makes the determination that CABAZITAXEL injection for intravenous use 60 mg/6 mL (10 mg/mL) [NDA 207970] held by Actavis, LLC, an indirect, wholly-owned subsidiary of Teva Pharmaceuticals USA, Inc. was not discontinued for reasons of safety or effectiveness.

2 docsNo comments

Nonrulemaking

DOT

Open for Comments

DOT-OST-2020-0035

Waiver of the Dormancy and Startup Conditions on Limited Entry Route Authority

113 docs20 comments

Nonrulemaking

EPA

EPA-HQ-OPP-2025-2863

EPA Extends Comment Time on Draft Rules Making Some Pesticide Label and Formula Changes Easier

4 docs34 comments

Nonrulemaking

FDA

FDA-2025-E-6103

Patent Term Extension Application for WAYRILZ (rilzabrutinib), Patent No. 9,994,576

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-6102

Patent Term Extension Application for WAYRILZ (rilzabrutinib), Patent No. 9,266,895

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-6101

Patent Term Extension Application for WAYRILZ (rilzabrutinib), Patent No. 8,940,744

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-6200

Patent Term Extension Application for VIVJOA (oteseconazole), Patent No. 8,236,962

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-6201

Patent Term Extension Application for RHAPSIDO (remibrutinib), Patent No. 9,512,084

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-3870

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 10,456,605

5 docsNo comments

Nonrulemaking

DEA

DEA-2026-0100

Drug Maker Seeks Federal OK to Make Bulk Controlled Substances

1 docNo comments

Nonrulemaking

FDA

FDA-2024-E-3869

Patent Term Extension Application Paradise Ultrasound Renal Denervation System, Patent No. 10,350,440

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-3868

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 10,039,901

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-3867

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 9,981,108

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-3866

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 9,943,666

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-5945

Patent Term Extension Application for NEXVIAZYME® (avalglucosidase alfa-ngpt), Patent No. 8,759,501

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0160

Patent Term Application for ITOVEBI (inavolisib). Patent No. 10,851,091

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0159

Patent Term Application for ITOVEBI (inavolisib), Patent No. 9,650,393

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-4133

Patent Term Extension Application for GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis, Patent No. 9,107,770

5 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0368

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 9,687,571

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0367

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 9,603,951

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0366

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 9,161,997

4 docsNo comments

Nonrulemaking

FDA

FDA-2026-H-1441

DAB Civil Money Penalty; Valor Vapes LLC d/b/a Smoke Art; CLOSED 3/25/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2025-E-0365

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 8,936,777

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0364

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 8,226,929

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-0363

Patent Term Application for FLYRCADO (flurpiridaz F 18), Patent No. 7,344,702

4 docsNo comments

Nonrulemaking

FDA

FDA-2025-E-6093

Patent Term Extension Application for FABHALTA (iptacopan), Patent No. 9,682,968

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-4365

Patent Term Extension Application for Edwards EVOQUE® Tricuspid Valve Replacement System, U.S. Patent No. 11,583,396

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-4364

Patent Term Extension Application for Edwards EVOQUE® Tricuspid Valve Replacement System, U.S. Patent No. 11,065,115

4 docsNo comments

Nonrulemaking

FDA

FDA-2024-E-4363

Patent Term Extension Application for Edwards EVOQUE® Tricuspid Valve Replacement System, U.S. Patent No. 10,687,939

4 docsNo comments